Role of stem cells on motor function recovery in stroke patients: systematic review

被引:0
作者
Raghuwanshi, Babita [1 ]
Thanneeru, Suresh K. [2 ]
Chanchalani, Roshan [2 ]
Raj, Sumit [3 ]
Chouksey, Pradeep [3 ]
Yunus, Md [4 ]
Agrawal, Amit [3 ]
机构
[1] All India Inst Med Sci, Dept Blood Bank & Transfus Med, Bhopal 462020, Madhya Pradesh, India
[2] All India Inst Med Sci, Dept Paediat Surg, Bhopal 462020, Madhya Pradesh, India
[3] All India Inst Med Sci, Dept Neurosurg, Bhopal 462020, Madhya Pradesh, India
[4] All India Inst Med Sci, Dept Trauma & Emergency Med, Bhopal 462020, Madhya Pradesh, India
关键词
Stroke; Mesenchymal stem cell; Motor recovery; fMRI; Biomarker; Cell therapy; Neuroimaging; Motor; Recovery; Motor activation; COLONY-STIMULATING FACTOR; ACUTE ISCHEMIC-STROKE; CLINICAL-TRIALS; THERAPY; METAANALYSIS; INJURY;
D O I
10.1186/s41984-025-00352-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundThe effectiveness of stem cell (SC) therapy for motor recovery in stroke patients remains debated within the scientific community.Aim/ObjectiveThis study aims to conduct a comprehensive systematic review and meta-analysis to evaluate the therapeutic potential of SC administration for motor recovery in stroke.MethodsA thorough search was performed on major electronic databases-PubMed, Scopus, ScienceDirect, and Cochrane-until August 15, 2023. Studies were selected based on predefined inclusion and exclusion criteria to ensure methodological rigor and relevance.ResultsThe initial search identified a substantial number of studies. After applying the selection criteria, a final set of eligible studies was reviewed. The extracted data covered various outcome measures related to motor recovery in stroke patients.ConclusionsAlthough some studies suggest the potential efficacy of stem cell therapy for motor recovery in stroke patients, the evidence lacks consistency. Future well-designed, robust randomized controlled trials are necessary to evaluate the efficacy, safety, and ethical implications of stem cell therapy for motor recovery in stroke patients.
引用
收藏
页数:8
相关论文
共 45 条
  • [1] Stem Cell Therapies for Ischemic Stroke: A Systematic Review
    Abdullahi, Abba Musa
    Abdullahi, Ibrahim Muhammad
    Sarmast, Shah T.
    Bhriguvanshi, Arpita
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [2] The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
    Barker, Timothy Hugh
    Stone, Jennifer C.
    Sears, Kim
    Klugar, Miloslav
    Tufanaru, Catalin
    Leonardi-Bee, Jo
    Aromataris, Edoardo
    Munn, Zachary
    [J]. JBI EVIDENCE SYNTHESIS, 2023, 21 (03) : 494 - 506
  • [3] Bhasin A, 2012, J STEM CELLS REGEN, V8, pP181
  • [4] Stemcell transplantation for ischemic stroke
    Boncoraglio, Giorgio Battista
    Ranieri, Michela
    Bersano, Anna
    Parati, Eugenio A.
    Del Giovane, Cinzia
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
  • [5] Predictors and Biomarkers of Treatment Gains in a Clinical Stroke Trial Targeting the Lower Extremity
    Burke, Erin
    Dobkin, Bruce H.
    Noser, Elizabeth A.
    Enney, Lori A.
    Cramer, Steven C.
    [J]. STROKE, 2014, 45 (08) : 2379 - 2384
  • [6] Functional reconstruction of the impaired cortex and motor function by hMGEOs transplantation in stroke
    Cao, Shi-Ying
    Tao, Meng-Dan
    Lou, Shu-Ning
    Yang, Di
    Lin, Yu-Hui
    Wu, Hai-Yin
    Chang, Lei
    Luo, Chun-Xia
    Xu, Yun
    Liu, Yan
    Zhu, Dong-Ya
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 671 : 87 - 95
  • [7] Probable Factors Associated with Response to Mesenchymal Stem Cell Therapy in Stroke Patients: A Post Hoc Analysis of the STARTING-2 Trial
    Chang, Won Hyuk
    Lee, Jungsoo
    Chung, Jong-Won
    Kim, Yun-Hee
    Bang, Oh Young
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [8] Treatment of neural injury with marrow stromal cells
    Chopp, M
    Li, Y
    [J]. LANCET NEUROLOGY, 2002, 1 (02) : 92 - 100
  • [9] Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke
    Chung, Jong-Won
    Chang, Won Hyuk
    Bang, Oh Young
    Moon, Gyeong Joon
    Kim, Suk Jae
    Kim, Soo-Kyoung
    Lee, Jin Soo
    Sohn, Sung-Il
    Kim, Yun-Hee
    [J]. NEUROLOGY, 2021, 96 (07) : E1012 - E1023
  • [10] The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents
    Cramer, Steven C.
    Koroshetz, Walter J.
    Finklestein, Seth P.
    [J]. STROKE, 2007, 38 (04) : 1393 - 1395